also naive to believe that management sitting on one strike with this much skin in the game will just sit back indefinitely and not seek to advance the co's MM market access and SP along with it... Far from flawless but they are positioning themselves as a pharma co and the timelines are longer than rippimng hemp out and jamming it into museli bars - I think the Edison report does a decent job at summarising, the company need to take a leaf out of that book and more clearly update progress and pipeline - not just vision statements etc
Where is?, page-356
-
- There are more pages in this discussion • 40 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RGT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
39.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $20.90M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2000 | 35.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 43.0¢ | 2500 | 1 |
View Market Depth
| Last trade - 16.12pm 18/10/2024 (20 minute delay) ? |
| RGT (ASX) Chart |
Day chart unavailable